Sort
82,697 grants matching “vaccine development”
Genetic and Biochemical Approaches to Tyrosine Kinase Function
$2,892,333Pamela Schwartzberg · Human Genome Research · Z01 · FY2007 · HG
Moffitt Cancer Center Support Grant
$2,891,925John L. Cleveland · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2019 · CA
OHSU Knight Cancer Institute
$2,891,535Brian J Druker · Oregon Health & Science University · P30 · FY2022 · CA
OHSU Knight Cancer Institute
$2,891,535Shivaani Kummar · Oregon Health & Science University · P30 · FY2025 · CA
OHSU Knight Cancer Institute
$2,891,535Lisa M Coussens · Oregon Health & Science University · P30 · FY2024 · CA
OHSU Knight Cancer Institute
$2,891,535Thomas A Sellers · Oregon Health & Science University · P30 · FY2023 · CA
MIDAS Center for Communicable Disease Dynamics
$2,891,265Marc Lipsitch · Harvard School Of Public Health · U54 · FY2012 · GM
BSL-4 Evaluation Core (Core B)
$2,890,889Thomas William Geisbert · University Of Texas Med Br Galveston · U19 · FY2023 · AI
Discovery of novel broad-spectrum coronavirus inhibitors
$2,888,994Vineet D Menachery · University Of Texas Med Br Galveston · U19 · FY2022 · AI
Alabama-Clinical Trials Unit
$2,886,842Michael S. Saag · University Of Alabama At Birmingham · U01 · FY2008 · AI
Universal Influenza Vaccine Development
$2,885,419Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
SPORE in Skin Cancer
$2,885,390Brigham And Women'S Hospital · P50 · FY2003 · CA
Bone Marrow Grafting for Leukemia and Lymphoma
$2,884,418Stanford University · P01 · FY2002 · CA
Vaccine Induced Immunity in the Young and Aged
$2,884,146Rafi Ahmed · Emory University · U19 · FY2014 · AI
Resources and Workforce Development for the Regional Biocontainment Laboratories
$2,883,009Herman F. Staats · Duke University · UC7 · FY2023 · AI
Project 3: Pandemic Virus Protease Inhibitors
$2,879,997Reuben S Harris · University Of Minnesota · U19 · FY2022 · AI
Immune Function and Biodefense in Children, Elderly, and the Immunocrompromised
$2,879,922Ignacio Sanz · University Of Rochester · N01 · FY2010 · AI
Advancing Public Health Research in Bangladesh
$2,879,788Sayera Banu · International Ctr/Diarrhoeal Dis Res · U01 · FY2021 · GH
Influenza Immunity: Protective Mechanisms Against Pandemic Respiratory Virus
$2,879,059Mark M Davis · Stanford University · U19 · FY2011 · AI
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination
$2,878,656Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2015 · AI
Columbia Collaborative HIV/AIDS Clinical Trials Unit
$2,878,282Scott M Hammer · Columbia University Health Sciences · U01 · FY2008 · AI
Research Resources and Workforce Development for the Rocky Mountain Regional Biocontainment Laboratory at Colorado State University
$2,877,411Karen Marie Dobos · Colorado State University · UC7 · FY2024 · AI
Targeting the Chemokine System to Sensitize Tumors to Immunotherapy
$2,875,855Pawel Kalinski · Roswell Park Cancer Institute Corp · P01 · FY2023 · CA
Immune signatures of vaccine responses in vulnerable populations
$2,874,261Ruth R Montgomery · Yale University · U19 · FY2022 · AI
Role of antigen-specific T cell responses in the control of TB
$2,872,556Henry M Blumberg · Emory University · U19 · FY2019 · AI